Stay updated on Dupilumab in Chronic Urticaria Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in Chronic Urticaria Clinical Trial page.

Latest updates to the Dupilumab in Chronic Urticaria Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision tag on the page updated to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.1%

- Check19 days agoChange DetectedRevision: v3.4.3 has been added, replacing the previous Revision: v3.4.2.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check47 days agoChange DetectedRevision: v3.4.2 was added and the prior government funding notice along with Revision: v3.4.1 were removed; this appears to be a site-wide administrative update rather than a change to study information.SummaryDifference0.4%

- Check54 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and updated the site revision to v3.4.1 (from v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check62 days agoChange DetectedGlossary display added and QC-related metadata updated (Last Update Submitted that Met QC Criteria) along with a site revision indicator (Revision: v3.4.0); the previous phrasing variant (Last Update Submitted that met QC Criteria) and 'No FEAR Act data' wording were removed.SummaryDifference0.2%

- Check76 days agoChange DetectedMinor site revision updated to v3.3.4 (replacing v3.3.3); no study content changed, and To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Dupilumab in Chronic Urticaria Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in Chronic Urticaria Clinical Trial page.